Constipation in Long (2)

《Constipation in Long (2)》由会员分享，可在线阅读，更多相关《Constipation in Long (2)（6页珍藏版）》请在装配图网上搜索。

1、Constipation in Long-Term CareISSN: 1524-7929 VOLUME: 16 PUBLICATION DATE: Dec 10 2008 author:Syed H. Tariq, MD, FACPAuthor Affiliations: Dr. Tariq is former Associate Professor of Internal Medicine and Geriatrics, Medical Director of the Acute Care of Elderly (ACE Unit), Division of Geriatric Medic

2、ine, Saint Louis University; and currently a Fellow, Division of Gastroenterology & Hepatology, St. Louis University School of Medicine, MO. The intestine tends to become sluggish with age.HippocratesNo organ in the body is so misunderstood, so slandered and maltreated as the colon.Sir Arthur Hurst,

3、 1935Constipation is reported in over 33 million adults, which makes it one of the most common problems in the United States. It accounts for 2.5 million physician visits and 92,000 hospitalizations each year. Constipation is seen in 25% of older persons.The term constipation can be very confusing.

4、While patients describe constipation as passing hard stool or straining to have a bowel movement, physicians, on the other hand, describe constipation as fewer than three bowel movements per week. Thus, both patient and physician are likely to be talking about two different sets of symptoms. For thi

5、s very reason, there is little correlation between self-reported constipation and number of bowel movements in epidemiologic surveys. The diagnostic criteria for constipation was created by a consensus conference in Rome, Italy, with the most recent updated information known as the Rome III Diagnost

6、ic Criteria. Epidemiology Frailty in older persons is very common and is associated with immobility, poor intake, and dehydration.1,2 It is, therefore, not surprising that constipation has been reported in 45% of frail elderly persons.3 The use of laxatives in the nursing home (NH) is reported in 50

7、% to 65% of residents.4-8 Half of these older persons took a daily laxative, yet only 62% of them actually met the criteria for constipation. Hence, there was minimal concordance between nurses and the NH residents for whether they were constipated. The use of laxatives is more common in those who a

8、re immobile, had Parkinsons disease or diabetes mellitus, or took iron supplements, calcium-channel antagonists, or antidepressants with anticholinergic activity.4In a study of 21,012 persons using the Minimum Data Set in NHs, the prevalence of constipation was 12.5%. The 3-month incidence was 7%. S

9、ome of the risk factors associated with constipation were race, decreased fluid intake, pneumonia, Parkinsons disease, and the presence of allergies. Congestive heart failure and the use of a feeding tube were two factors identified as having a protective effect.9Economic Impact and Quality of Life

10、The National Health Service in the United Kingdom reported annual prescription laxative cost at 43 million pounds,10 while the average cost of treating constipation in the United States in NHs is $2253 per resident per year.11 Constipation in older persons is associated with a decline in quality of

11、life, a decrease in functional ability, increased pain, dysuria, fecal incontinence, stercoral ulcers, and fecaloma.12-17 One of the major problems associated with constipation is the development of fecal impaction leading to intestinal obstruction, bowel perforation, and even death.18,19Delirium is

12、 a common reason for hospital admission,20 and constipation is a common cause of delirium.21 Constipation is also reported to be associated with physical and verbal aggression.22 The cost of treating constipation does not include the adverse outcomes resulting from not treating constipation appropri

13、ately.Causes of Constipation The causes of constipation can be divided into mechanical causes, metabolic causes, neurologic diseases, psychiatric diseases, and medications. Mechanical obstruction is caused by colon cancer, strictures, and anal stenosis. Diabetes mellitus is associated with autonomic

14、 neuropathy and altered colonic transit time. Hypercalcemia and hypomagnesia slow intestinal transit. Hypothyroidism commonly presents with constipation. Amyloidosis and scleroderma are rare causes of constipation. Cancer and terminal illness commonly are associated with constipation.23 Parkinsons d

15、isease, stroke, dementia, and depression are all associated with constipation.Older persons tend to be taking large numbers of medicines, a number of which are related to constipation.24 The best recognized of these are opiates and iron and calcium supplements; with the increased awareness of the da

16、ngers of osteoporosis in older persons, there is increasing use of calcium supplements.25 Antidepressants with anticholinergic activity, which include both tricyclics and selective serotonin reuptake inhibitors (eg, paroxetine), lead to constipation, as do antipsychotics and antihistamines. Diuretic

17、s result in dehydration. Antiparkinsonian agents, such as L-dopa and bromocriptine, slow intestinal transit. Perhaps the major unrecognized cause of constipation in older persons are calcium-channel antagonists.Evaluation of ConstipationWhen evaluating a patient with constipation it is important to

18、look for red flag signs such as acute onset of constipation, weight loss, rectal bleeding, iron deficiency anemia, and family history of colon cancer. If any of the red flag signs are present, patients need urgent evaluation and referral to a gastroenterologist for colonoscopy. A careful general phy

19、sical examination is required to explore evidence for possible systemic disorder, excluding fecal impaction and assessment of anorectal function. Inspection and digital rectal examination of the anal sphincter at rest, with squeezing, and with straining, are important in determining sphincter integr

20、ity, perineal descent, and rectal masses.Basic tests for an individual with chronic constipation include a complete blood count, serum blood urea nitrogen, serum creatinine, serum sodium, serum calcium, serum magnesium, a thyroid-stimulating hormone level, and stool for occult blood. Sigmoidoscopy o

21、r colonoscopy should be considered for any person with prolonged chronic constipation. An abdominal x-ray is also important to exclude fecal impaction. Some of the additional tests that can be helpful include colon transit measurements, colonic manometry, anorectal manometry, balloon expulsion testi

22、ng, and defecography.26,27Management of Constipation: The basic management of constipation includes: Adequate fluid intake Bulking agents Toileting ExerciseFiber is generally a safe, inexpensive, first-line approach, which improves stool consistency and accelerates colon transit time. Increase in fl

23、uid intake may be helpful in persons with dehydration but rarely improves symptoms of constipation in the individual with chronic constipation.28 Similarly, increase in physical activity is also recommended without any clear evidence.29,30 Studies with psyllium generally show improvement in stool fo

24、rm and frequency.31,32 Stool softeners in the treatment of chronic constipation have not been shown to be superior to psyllium.33,34Osmotic laxatives include polyethylene glycol (PEG), lactulose, sorbitol, magnesium salts, and saline salts. Saline and magnesium salts should not be used in persons wi

25、th renal or liver disease or heart failure. One study showed that lactulose improved stool frequency, reduced need for enemas, and reduced fecal impaction over a 12-week period.35 In a randomized controlled trial of lactulose and sorbitol, there was no difference in the laxative effect or strong pre

26、ference of one laxative over another in the study population.36 Abdominal symptoms were similar between the two groups except for greater complaints of nausea in lactulose group. The cost of sorbitol is generally less and makes it a preferred agent for many persons.36Stimulant laxatives, when used i

27、n recommended doses and for short duration, are less likely to harm the colon. However, stimulant laxatives do result in electrolyte imbalance or abdominal pain in some persons. Combination laxatives, including a senna-containing concentrate or a stool softener and fiber, resulted in improved bowel

28、evacuation and prevention of fecal impaction in NH residents.37 The role of an enema in the treatment of constipation is limited to acute situations. Any enema must be used with caution owing to the risk of colonic perforation. Soap enemas should not be used. Small-volume tap water enemas may be hel

29、pful in emptying the rectum; large-volume can also be used but can result in hyponatremia. Enemas containing phosphate are described to cause hyperphosphatemia, especially in persons with renal insufficiency. Lubiprostone is the latest drug approved for the treatment of chronic idiopathic constipati

30、on by the Food and Drug Administration (FDA). It activates the specific chloride channels (CIC-2) in the lining of the small intestine after oral administration, thereby increasing intestinal fluids. Lubiprostone 24 mcg twice daily results 57% of the time in spontaneous bowel movement within 24 hour

31、s as compared to placebo 37%. The major side effects of lubiprostone are nausea, diarrhea, headache, abdominal pain, flatulence, sinusitis, and vomiting. In clinical trials, lubiprostone 24 mcg is used, administered twice daily orally. Lubiprostone should be used when the currently available agents

32、are not effective in the treatment of constipation.38Two studies showed the long-term effects of PEG in the treatment of chronic constipation, evaluating the safety and efficacy at 6 months and 1 year. Although it is not approved by the FDA, in clinical practice it is a reasonable option for selecte

33、d patients.39,40Refractory constipation is rare in older adults. Although data show that younger patients with refractory constipation and slow transit time may benefit from subtotal colectomy and ileorectostomy, this is rarely required, as most patients respond to laxatives. Summary of Nursing Home

34、 Protocol Any older person who complains of constipation should have depression considered as a diagnosis and should increase fluid and fiber (if mobile), toilet after meals, and increase exercise. In all persons with chronic constipation, any offending agent that could cause constipation should be

35、stopped if possible. Thyroid-stimulating hormone, calcium magnesium, and stool checks for blood should be done. An osmotic laxative such as sorbitol, lactulose, or PEG should be used in selected individuals. If the person has weight loss, rectal bleeding, or iron deficiency anemia, a colonoscopy sho

36、uld be obtained. If there is no response to an osmotic laxative, lubiprostone 24 mcg twice daily should be used. Treatment should be continued for 4 weeks and then withdrawn. If there is a relapse, one should try the osmotic laxative, and/or short-term use of stimulant and/or an enema if the individ

37、ual desires. If there is no response, the individual should be restarted on lubiprostone. If problems with constipation continue, a referral to a gastroenterologist is mandatory. The author has received speaker honoraria from Sucampo Pharmaceuticals.References:1. Morley JE, Kim MJ, Haren MT, et al.

38、Frailty and the aging male. Aging Male 2005;8:135-140. 2. Morley JE, Perry HM 3rd, Miller DK. Editorial: Something about frailty. J Gerontol A Biol Sci Med Sci 2002;57:M698-M704. 3. Wolfsen CR, Barker JC, Mitteness LS. Constipation in the daily lives of frail elderly people. Arch Fam Med 1993;2:853-

39、858. 4. Harari D, Gurwitz JH, Avorn J, et al. Correlates of regular laxative use by frail elderly persons. Am J Med 1995;99:513-518. 5. Harari D, Gurwitz JH, Avorn J, et al. Constipation: Assessment and management in an institutionalized elderly population. J Am Geriatr Soc 1994;42:947-952. 6. Lamy

40、PP, Krug BH. Review of laxative utilization in a skilled nursing facility. J Am Geriatr Soc 1978;26:544-549. 7. Marfil C, Davies GJ, Dettmar PW. Straining at stool and stool frequency in free-living and institutionalised older adults. J Nutr Health Aging 2005;9:277-280. 8. Frank L, Schmier J, Kleinm

41、an L, et al. Time and economic cost of constipation care in nursing homes. J Am Med Dir Assoc 2002;3:215-223. 9. Robson KM, Kiely DK, Lembo T. Development of constipation in nursing home residents. Dis Colon Rectum 2000;43(7);940-943. 10. Petticrew M, Watt I, Sheldon T. Systematic review of the effe

42、ctiveness of laxatives in the elderly. Health Technology Assessment 1997;1(13):i-iv, 1-52. 11. Frank L, Schmier J, Kleinman, et al. Time and economic cost of constipation care in nursing homes. J Am Med Dir Assoc 2002;3(4):215-223. 12. Norton C. Constipation in older patients: Effects on quality of

43、life. Br J Nurs 2006;15:188-192. 13. Tariq SH, Morley JE, Prather CM. Fecal incontinence in the elderly patient. Am J Med 2003;115:217-227. 14. Akhtar AJ, Padda M. Fecal incontinence in older patients. J Am Med Dir Assoc 2005;6:54-60. 15. Phillips C, Polakoff D, Maue SK, Mauch R. Assessment of const

44、ipation management in long-term care patients. J Am Med Dir Assoc 2001;2:149-154. 16. Rajagopal A, Martin J. Giant fecaloma with idiopathic sigmoid megacolon: Report of a case and review of the literature. Dis Colon Rectum 2002;45:833-835. 17. Potter J, Wagg A. Management of bowel problems in older

45、people: An update. Clin Med 2005;5:289-295. 18. Sufian S, Matsumoto T. Intestinal obstruction. Am J Surg 1975;130:9-14. 19. Read NW, Abouzekry L. Why do patients with faecal impaction have faecal incontinence. Gut 1986;27:283-287. 20. Flaherty JH, Tariq SH, Raghavan S, et al. A model for managing de

46、lirious older inpatients. J Am Geriatr Soc 2003;51:1031-1035. 21. Ross DD, Alexander CS. Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea. Am Fam Physician 2001;64:1019-1026. 22. Leonard R, Tinetti ME, Allore HG, Drickamer MA. Potentially modifiab

47、le resident characteristics that are associated with physical or verbal aggression among nursing home residents with dementia. Arch Intern Med 2006;166:1295-1300. 23. Cartwright JC, Hickman S, Perrin N, Tilden V. Symptom experiences of residents dying in assisted living. J Am Med Dir Assoc 2006;7:21

48、9-223. Published Online: November 23, 2005. 24. Flaherty JH, Perry HM 3rd, Lynchard GS, Morley JE. Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 2000;55:M554-M559. 25. Kamel HK, Hussain MS, Tariq S, et al. Failure to diagnose and treat osteoporosis in

49、 elderly patients hospitalized with hip fracture. Am J Med 2000;109:326-328. 26. Tariq SH. Constipation in long term care. J Am Med Dir Assoc 2007;8(4):209-218. 27. Tariq SH. Q & A. How to manage constipation in the long-term care setting. Annals of Long-Term Care: Clinical Care and Aging 2006:15:4-

50、7. 28. Mller-Lissner SA, Kamm MA, Scarpignato C, Wald A. Myths and misconceptions about chronic constipation. Am J Gastroenterol 2005;100:232-242. 29. Higgins PD, Johanson JF. Epidemiology of constipation in North America: A systematic review. Am J Gastroenterol 2004;99:750-759. 30. Badiali D, Coraz

51、ziari E, Habib FI, et al. Effect of wheat bran in treatment of chronic nonorganic constipation. A double-blind controlled trial. Dig Dis Sci 1995;40:349-356. 31. Cheskin LJ, Kamal N, Crowell MD, et al. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Geria

52、tr Soc 1995;43(6):666-669. 32. Castle SC, Cantrell M, Israel DS, Samuelson MJ. Constipation prevention: Empiric use of stool softeners questions. Geriatrics 1991;46:84-86. 33. McRorie JW, Daggy BP, Morel JG, et al. Psyllium is superior to docusate sodium for treatment of chronic constipation. Alimen

53、t Pharmacol Ther 1998;12:491-497. 34. Corazziari E, Badiali D, Bazzocchi G, et al. Long term efficacy, safety, and tolerability of low daily doses of isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in the treatment of functional chronic constipation. Gut 2000;46:522-526. 35. Sa

54、nders JF. Lactulose syrup assessed in a double-blind study of elderly constipated patients. J Am Geriatr Soc 1978;26:236-239. 36. Lederle FA, Busch DL, Mattox KM, et al. Cost-effective treatment of constipation in the elderly: A randomized double-blind comparison of sorbitol and lactulose. Am J Med

55、1990;89:597-601. 37. Maddi VI. Regulation of bowel function by a laxative/stool softener preparation in aged nursing home patients. J Am Geriatr Soc 1979;27:464-468. 38. Orr KK. A novel chloride channel activator for the treatment of constipation. Formulary 2006;41:118-129. 39. Dipalma JA, Cleveland

56、 MV, McGowen, et al. A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol 2007;102(7):1436-1441. Published Online: March 31, 2007. 40. Dipalma JA, Cleveland MV, McGowen, et al. An open-label study of chronic polyethylene glycol laxative use in chronic constipation. Aliment Pharmacol Ther 2007;15;25(6):703-708.